Transfusion Management for Patients with Sickle Cell Disease
| المؤلف الرئيسي: | Al Battal, Fahad Mohammad (Author) |
|---|---|
| التاريخ الميلادي: |
2011
|
| موقع: | ملبورن |
| الصفحات: | 1 - 25 |
| رقم MD: | 752494 |
| نوع المحتوى: | رسائل جامعية |
| اللغة: | الإنجليزية |
| الدرجة العلمية: | رسالة ماجستير |
| الجامعة: | RMIT University |
| الكلية: | School of Medical Science |
| الدولة: | أستراليا |
| قواعد المعلومات: | +Dissertations |
| مواضيع: | |
| رابط المحتوى: |
الناشر لهذه المادة لم يسمح بإتاحتها. |
| المستخلص: |
Sickle cell disease (SCD) is considered a multisystem disease caused by the inheritance of the mutated hemoglobin S (HbS). the diseases involves two common features, sickle shaped erythrocytes and the presence of several complications related to the disease, such as, stroke, anemia, vaso-occlusive and multi organ failure. The disease is treated mainly through three techniques: hydroxyurea, bone marrow transplantation and blood transfusion. Blood transfusion is considered the most common therapy among the three. This review focuses on the techniques used to reduce the complications of blood transfusion in patients who have SCD. The review’s content has been gathered electronically through exploring RMIT library database which includes Science Direct website, First Web of Knowledge website and Pub Med website.Basedupon six studies covered the topic the reduction of blood transfusion complication in sickle cell disease patients the result showed that automated erythrocytapheresis (ECP)Procedure is the most promising transfusion method, it reduces HbS levels to less than 30% of the total Hb in the body,and it prevents iron overload. In addition, it is noted that the procedure minimizes the alloimmunization and transmission infectious diseases. ECP is considered a beneficial therapy since it controls SCD complications and improves the patient’s clinical outcome. |
|---|
عناصر مشابهة
-
A Crittical Assessment of the Pre-Marital Carriers Screening Programme for Sickle Cell Anaemia an thalassaemia in Sudia Arabia Population 2004 and 2005
بواسطة: Al Ghamdi, Saleh Ali منشور: (2006) -
Long-term efficacy and safety of Hydroxycarbamide for pediatric sickle cell disease: Research Project MEDS2138_1210 Non-lab based Project
بواسطة: Al Yahiwi, Hanan Eid منشور: (2012) -
ASSOCIATION OF HUMAN PLATELET ALLOANTIGENS (HPA)-1 THROUGH HPA-5 POLYMORPHISM IN BAHRAINI ARABS SICKLE CELL DISEASE PATIENTS
بواسطة: Al Subaie, Abeer Mohammed منشور: (2007) -
GSTM1 polymorphisms and Severity of Sickle Cell Anaemia
بواسطة: Jamel, Saadia Osman Abd Alraheem منشور: (2017) -
Assesment Of Pain In Children With Sickle Cell Disease In Khartoum State 2015-2016
بواسطة: Ibrahim, Rabia Yahya منشور: (2016)
